$CLVT
CLARIVATE PLC Stock $clvt

$clvt Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000176404621000165 Filed on October 28, 2021

Income Statement

Concept	2021 Q3	2020 Q4	2020 Q3
Revenue	$442.1M	$455.6M	$284.4M
YoY Change	55.48%	78.66%	17.02%
Cost Of Revenue	$141.1M	$134.1M	$93.55M
YoY Change	50.83%	62.55%	7.41%
Gross Profit	$301.0M	$321.5M	$190.8M
YoY Change	57.75%	86.38%	22.39%
Gross Profit Margin	68.08%	70.57%	67.1%
Selling, General & Admin	$141.2M	$186.1M	$131.5M
YoY Change	7.37%	100.97%	36.98%
% of Gross Profit	46.92%	57.88%	68.93%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.657M	$127.0M	$2.918M
YoY Change	-8.94%	129.66%	27.93%
% of Gross Profit	0.88%	39.5%	1.53%
Operating Expenses	$141.2M	$244.2M	$297.0M
YoY Change	-52.46%	67.03%	43.38%
Operating Profit	$14.38M	-$9.621M	-$12.66M
YoY Change	-213.51%	-41.45%	256.23%
Interest Expense	$65.19M	-$39.60M	$20.24M
YoY Change	222.04%	-37.93%	-13.37%
% of Operating Profit	453.52%
Other Income/Expense, Net
YoY Change
Pretax Income	$26.89M	-$10.10M	-$177.7M
YoY Change	-115.14%	-87.41%	-1524.14%
Income Tax	$3.579M	-$16.50M	$4.325M
% Of Pretax Income	13.31%
Net Earnings	$23.31M	-$13.73M	-$182.0M
YoY Change	-112.81%	-83.81%	-1780.23%
Net Earnings / Revenue	5.27%	-3.01%	-64.0%
Basic Earnings Per Share	$0.01	-$0.02	-$0.47
Diluted Earnings Per Share	-$0.12	-$0.05	-$0.47
COMMON SHARES
Basic Shares Outstanding	634.5M shares	606.0M shares	387.8M shares
Diluted Shares Outstanding	643.9M shares		387.8M shares

Balance Sheet

Concept	2021 Q3	2020 Q4	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.480B	$258.0M	$601.0M
YoY Change	312.63%	239.47%	575.28%
Cash & Equivalents	$2.480B	$257.7M	$601.1M
Short-Term Investments
Other Short-Term Assets	$186.3M	$79.15M	$18.67M
YoY Change	897.74%	573.62%	-59.41%
Inventory
Prepaid Expenses	$58.06M	$58.27M	$49.24M
Receivables	$610.8M	$737.7M	$238.6M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$5.189B	$1.148B	$944.3M
YoY Change	449.56%	132.74%	161.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.95M	$36.27M	$23.62M
YoY Change	18.33%	101.01%	-78.91%
Goodwill	$6.199B	$6.043B	$1.818B
YoY Change	240.9%	355.03%
Intangibles	$6.964B	$7.370B	$2.217B
YoY Change	214.09%	303.05%
Long-Term Investments
YoY Change
Other Assets	$41.81M	$31.33M	$21.84M
YoY Change	91.46%	68.17%	-44.01%
Total Long-Term Assets	$13.31B	$13.64B	$4.206B
YoY Change	216.38%	313.64%	27.89%
TOTAL ASSETS
Total Short-Term Assets	$5.189B	$1.148B	$944.3M
Total Long-Term Assets	$13.31B	$13.64B	$4.206B
Total Assets	$18.50B	$14.79B	$5.151B
YoY Change	259.13%	290.11%	41.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$94.49M	$82.04M	$19.90M
YoY Change	374.89%	210.07%	-28.94%
Accrued Expenses	$556.9M	$752.0M	$279.0M
YoY Change	99.6%	315.47%	50.0%
Deferred Revenue	$579.9M	$707.3M	$326.1M
YoY Change	77.84%	73.65%	-1.42%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.866B	$28.60M	$12.60M
YoY Change	14706.56%	217.78%	-16.0%
Total Short-Term Liabilities	$3.161B	$1.423B	$662.7M
YoY Change	377.04%	118.6%	18.34%
LONG-TERM LIABILITIES
Long-Term Debt	$3.444B	$3.458B	$1.911B
YoY Change	80.2%	112.32%	46.44%
Other Long-Term Liabilities	$58.33M	$49.45M	$19.99M
YoY Change	191.81%	161.74%	-94.64%
Total Long-Term Liabilities	$3.502B	$3.507B	$1.931B
YoY Change	81.35%	112.89%	15.08%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.161B	$1.423B	$662.7M
Total Long-Term Liabilities	$3.502B	$3.507B	$1.931B
Total Liabilities	$7.287B	$5.756B	$2.792B
YoY Change	160.97%	136.78%	22.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.317B	-$1.251B	-$965.3M
YoY Change	36.47%	48.34%
Common Stock	$10.81B	$9.989B	$3.329B
YoY Change	224.75%	352.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	6.326M shares	0.000 shares
Shareholders Equity	$11.21B	$9.035B	$2.022B
YoY Change
Total Liabilities & Shareholders Equity	$18.50B	$14.79B	$5.151B
YoY Change	259.13%	290.11%	41.12%

Cashflow Statement

Concept	2021 Q3	2020 Q4	2020 Q3
OPERATING ACTIVITIES
Net Income	$23.31M	-$13.73M	-$182.0M
YoY Change	-112.81%	-83.81%	-1780.23%
Depreciation, Depletion And Amortization	$2.657M	$127.0M	$2.918M
YoY Change	-8.94%	129.66%	27.93%
Cash From Operating Activities	$43.85M	$135.5M	$20.40M
YoY Change	114.95%	2556.86%	-70.69%
INVESTING ACTIVITIES
Capital Expenditures	-$24.18M	-$29.10M	-$26.00M
YoY Change	-7.02%	11.07%	21.5%
Acquisitions
YoY Change
Other Investing Activities	-$14.75M	-$1.997B	$0.00
YoY Change		2819.44%
Cash From Investing Activities	-$38.92M	-$2.026B	-$26.00M
YoY Change	49.7%	2041.65%	21.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-231.4M	1.557B	-6.200M
YoY Change	3632.53%	1862.8%	67.57%
NET CHANGE
Cash From Operating Activities	43.85M	135.5M	20.40M
Cash From Investing Activities	-38.92M	-2.026B	-26.00M
Cash From Financing Activities	-231.4M	1.557B	-6.200M
Net Change In Cash	-226.5M	-334.0M	-11.80M
YoY Change	1819.42%	3174.51%	-126.52%
FREE CASH FLOW
Cash From Operating Activities	$43.85M	$135.5M	$20.40M
Capital Expenditures	-$24.18M	-$29.10M	-$26.00M
Free Cash Flow	$68.03M	$164.6M	$46.40M
YoY Change	46.61%	425.88%	-49.01%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Y9
	dei	Entity Central Index Key EntityCentralIndexKey	0001764046
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38911
	dei	Entity Registrant Name EntityRegistrantName	CLARIVATE PLC
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Friars House,
	dei	Entity Address Address Line1 EntityAddressAddressLine1	160 Blackfriars Road
	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2020Q4	us-gaap	Debt Current DebtCurrent	28600000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3161236000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1569767000	USD
CY2021Q3	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3443578000	USD
CY2020Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3457900000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	195952000	USD
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	312751000	USD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	SE1 8EZ
	dei	Entity Address Country EntityAddressCountry	GB
	dei	Country Region CountryRegion	44
	dei	City Area Code CityAreaCode	207
	dei	Local Phone Number LocalPhoneNumber	4334000
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	639776102	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2479880000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	257730000	USD
CY2021Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	1854257000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	11278000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8642000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	44934000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	41399000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	58332000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	67722000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	324959000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	362261000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	610755000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58056000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	58273000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	186298000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	262494000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	5189246000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	1327508000	USD
CY2021Q3	clvt	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	27948000	USD
CY2020Q4	clvt	Computer Hardware And Other Property Net ComputerHardwareAndOtherPropertyNet	36267000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6964081000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7370350000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	6198701000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6252636000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	41808000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	47944000	USD
CY2021Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	30110000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	29786000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	45880000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	132356000	USD
CY2021Q3	us-gaap	Assets Assets	18497774000	USD
CY2020Q4	us-gaap	Assets Assets	15196847000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	94494000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	82038000	USD
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	592721000	USD
CY2020Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	716356000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	579935000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	707318000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	28459000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	35455000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	1865627000	USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	58443000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	104324000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	7287434000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	5916124000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	14375000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	14375000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	14375000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	1392671000	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	639750620	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	639750620	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	606329598	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	606329598	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	10810130000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	9989284000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	324904000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	503521000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1317365000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1212082000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	11210340000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9280723000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	18497774000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15196847000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	442117000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284360000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	141111000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	93554000	USD
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	141219000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131526000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	2657000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	2918000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	128026000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	65696000	USD
CY2021Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	15621000	USD
CY2020Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	3192000	USD
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4411000	USD
CY2020Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-138000	USD
CY2021Q3	us-gaap	Costs And Expenses CostsAndExpenses	433045000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	297024000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	9072000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12664000	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-83013000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	144753000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	92085000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-157417000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	65194000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	20244000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26891000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-177661000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3579000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	881000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	881000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-181986000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-181986000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	640834827	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	387845438	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	645933513	shares
	us-gaap	Depreciation Depreciation	8151000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	383270000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-36887000	USD
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	387845438	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	798452000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	416459000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	268614000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	402378000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	368247000	USD
	us-gaap	Depreciation Depreciation	9243000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	168049000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	121988000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	26792000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-19741000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	14675000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1353079000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	825178000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26726000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113207000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13693000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	224175000	USD
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	76320000	USD
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-250901000	USD
	us-gaap	Interest Expense InterestExpense	141156000	USD
	us-gaap	Interest Expense InterestExpense	72306000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64836000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-323207000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18016000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-105283000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105283000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-336900000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10436000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-336900000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	622460931	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	369019802	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	622460931	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	369019802	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	333000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1092000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	4000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	15000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-246979000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9359000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-178617000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2415000	USD
CY2021Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-223338000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-171550000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1884000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2052000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	12000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	57000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-180489000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1795000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-261469000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-337214000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	9280723000	USD
CY2021Q1	clvt	Stock Issued During Period Value Private Warrants Exercised StockIssuedDuringPeriodValuePrivateWarrantsExercised	3592000	USD
CY2021Q1	clvt	Stock Issued During Period Value Private Warrants Exercised StockIssuedDuringPeriodValuePrivateWarrantsExercised	3592000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5074000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	4489000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	105509000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	10479000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-23954000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	19838000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	9396772000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9761000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	17245000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12816000	USD
CY2021Q2	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	0	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-82210000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	48195000	USD
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	641419578	shares
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	641419578	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11490079000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	-279000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10302000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13649000	USD
CY2021Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	65215000	USD
CY2021Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	6290000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
CY2021Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-246650000	USD
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	639750620	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	639750620	shares
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	11210340000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1248599000	USD
CY2020Q1	clvt	Stock Issued During Period Value Public Warrants Exercised StockIssuedDuringPeriodValuePublicWarrantsExercised	277526000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	539714000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16384000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	392513000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	3136000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5520000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1925681000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	15118000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	304030000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4322000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-25281000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2280000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2191354000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10436000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	2022313000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176200000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6832000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1830000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-11084000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7420000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	36944000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	26344000	USD
	clvt	Noncash Impairment Leases NoncashImpairmentLeases	60232000	USD
	clvt	Noncash Impairment Leases NoncashImpairmentLeases	4880000	USD
	clvt	Gain Loss On Foreign Currency Forward Contracts GainLossOnForeignCurrencyForwardContracts	-4026000	USD
	clvt	Gain Loss On Foreign Currency Forward Contracts GainLossOnForeignCurrencyForwardContracts	2903000	USD
	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	-34503000	USD
	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	30839000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113207000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	224175000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	0	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1052000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-9050000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-3140000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3565000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	3902000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-114038000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-129398000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	887000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13335000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-60749000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-62818000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	13550000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8394000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-14208000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-65062000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-116312000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-93926000	USD
	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-16838000	USD
	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5826000	USD
	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	37362000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	3751000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-100511000	USD
	clvt	Proceeds From Debt Restructure ProceedsFromDebtRestructure	360000000	USD
	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	6611000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-2407000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2077000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	305515000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	128022000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	86197000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	78597000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	14314000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	885323000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5982000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-966151000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2000000000	USD
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	157424000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	21450000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	9450000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	65000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7471000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5267000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4115000	USD
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1392671000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	728080000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	843752000	USD
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	65215000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	1000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	17250000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1307000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	21455000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28674000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3864985000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1370079000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-4860000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6447000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4065129000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	525503000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	257730000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2020Q4	us-gaap	Restricted Cash RestrictedCash	11278000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	269008000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76139000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4334137000	USD
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	22.50
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	601642000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2479880000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	601075000	USD
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	1854257000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	567000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4334137000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	601642000	USD
	us-gaap	Interest Paid Net InterestPaidNet	97401000	USD
	us-gaap	Interest Paid Net InterestPaidNet	61796000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	22387000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	20147000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	6612000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	922000	USD
	us-gaap	Treasury Stock Retired Cost Method Amount TreasuryStockRetiredCostMethodAmount	5117380000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	16141000	USD
CY2021Q3	us-gaap	Preferred Stock Amount Of Preferred Dividends In Arrears PreferredStockAmountOfPreferredDividendsInArrears	6289000	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
	us-gaap	Stock Issued1 StockIssued1	62724000	USD
	us-gaap	Nature Of Operations NatureOfOperations	Background and Nature of Operations <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clarivate Plc (“Clarivate,” “us,” “we,” “our,” or the “Company”), is a public limited company organized under the laws of Jersey, Channel Islands. We were initially registered on January 7, 2019, and at our 2020 annual general meeting, our shareholders approved a change of our corporate name from “Clarivate Analytics Plc” to “Clarivate Plc”. Pursuant to the definitive agreement entered into to effect a merger between Camelot Holdings (Jersey) Limited ("Jersey") and Churchill Capital Corp, a Delaware corporation, ("Churchill") (the “2019 Transaction”), the Company was formed for the purposes of completing the 2019 Transaction and related transitions and carrying on the business of Jersey and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a provider of proprietary and comprehensive content, analytics, professional services and workflow solutions that enable users across government and academic institutions, life science companies and research and development (“R&D”) intensive corporations to discover, protect and commercialize their innovations. Clarivate has two reportable segments: Science and Intellectual Property ("IP"). Our segment structure is organized to address customer needs by product line. Our Science segment consists of our Academic and Life Sciences Product Lines. Both provide curated, high-value, structured information that is delivered and embedded into the workflows of our customers, which include research intensive corporations, life science organizations and universities world-wide. Our IP segment consists of our Patent, Trademark, Domain and IP Management Product Lines. These Product Lines help manage customer's end-to-end portfolios of intellectual property from patents to trademarks to corporate website domains. See Note 21 - Segment Information, for additional information on the Company's reportable segments. </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2019, we entered into an Agreement and Plan of Merger (as amended by Amendment No. 1 to the Agreement and Plan of Merger, dated February 26, 2019, and Amendment No. 2 to the Agreement and Plan of Merger, dated March 29, 2019, collectively, the “Merger Agreement”) by and among Churchill, Jersey, CCC Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Clarivate (“Delaware Merger Sub”), Camelot Merger Sub (Jersey) Limited, a private limited company organized under the laws of Jersey, Channel Islands and wholly owned subsidiary of Clarivate (“Jersey Merger Sub”), and the Company, which, among other things, provided for (i) Jersey Merger Sub to be merged with and into Jersey with Jersey being the surviving company in the merger (the “Jersey Merger”) and (ii) Delaware Merger Sub to be merged with and into Churchill with Churchill being the surviving corporation in the merger (the “Delaware Merger”), and together with the Jersey Merger, the “Mergers”.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On May 13, 2019, the 2019 Transaction was consummated, and Clarivate became the sole managing member of Jersey, operating and controlling all of the business and affairs of Jersey, through Jersey and its subsidiaries. Following the consummation of the 2019 Transaction on May 13, 2019, the Company’s ordinary shares and warrants began trading on the New York Stock Exchange. All of the Company’s public warrants have subsequently been redeemed. See Note 16 - Shareholders’ Equity for further information regarding the redemption of the Company’s public warrants.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2019 Transaction was accounted for as a reverse recapitalization in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). Under this method of accounting, Churchill was treated as the "acquired" company for financial reporting purposes. This determination was primarily based on post 2019 Transaction relative voting rights, composition of the governing board, size of the two entities pre-merger, and intent of the 2019 Transaction. Accordingly, for accounting purposes, the 2019 Transaction was treated as the equivalent of the Company issuing stock for the net assets of Churchill. The net assets of Churchill were stated at historical cost, with no goodwill or other intangible assets resulting from the 2019 Transaction. Reported amounts from operations included herein prior to the 2019 Transaction are those of Jersey.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company consummated a public offering of 27,600,000 ordinary shares at $20.25 per share. In June 2020, the Company consummated a public offering of 50,400,000 of our ordinary shares at a share price of $22.50 per share. Of the 50,400,000 ordinary shares, 14,000,000 were ordinary shares offered by Clarivate and 36,400,000 were ordinary shares offered by selling shareholders. The Company received approximately $304,030 in net proceeds from the sale of its ordinary shares, after deducting underwriting discounts and estimated offering expenses payable. We used the net proceeds, in conjunction with the new $1,600,000 incremental term loan facility available to Clarivate on October 1, 2020, and cash on the balance sheet to fund the repayment of CPA Global's parent company outstanding debt of $2,055,822. The Company did not receive any proceeds from the sale of ordinary shares by the selling shareholders. Additionally, in connection with the acquisition of CPA Global, on October 1, 2020, the Company issued 216,683,778 shares to Redtop Holdings Limited, a portfolio company of Leonard Green & Partners, L.P. representing approximately 35% ownership of Clarivate.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, we completed an underwritten public offering of 50,400,000 of our ordinary shares (including 2,400,000 ordinary shares pursuant to the underwriters' option to purchase up to an additional 7,200,000 ordinary shares from certain selling shareholders) at a share price of $22.50. Of the 50,400,000 ordinary shares, 14,000,000 ordinary shares were offered by Clarivate and 36,400,000 ordinary shares were offered by selling shareholders, including 20,821,765 ordinary shares from Onex, 8,097,354 ordinary shares from Baring and 7,480,881 ordinary shares from Directors, Executive Officers and other shareholders. The underwriters' option to purchase the remaining 4,800,000 ordinary shares from certain selling shareholders expired on July 3, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received approximately $304,030 in net proceeds from the sale of ordinary shares offered by the Company, after deducting underwriting discounts and estimated offering expenses payable. We used the net proceeds, in conjunction with the new $1,600,000 incremental term loan facility available to Clarivate on October 1, 2020, to fund the repayment of CPA Global parent company's outstanding debt. The Company did not receive any proceeds from the secondary ordinary shares sold by the selling shareholders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we completed an underwritten public offering of 44,230,768 of our ordinary shares at a share price of $26.00, of which 28,846,154 ordinary shares were issued and sold by Clarivate and 15,384,614 were sold by selling shareholders (which included 5,769,230 ordinary shares that the underwriters purchased pursuant to their option to purchase additional shares). The ordinary shares sold by selling shareholders included 10,562,882 ordinary shares from Onex, 4,107,787 ordinary shares from Baring and 713,945 ordinary shares from Directors, Executive Officers and other shareholders. The Company received approximately $728,080 in net proceeds from the sale of ordinary shares offered by the Company, after deducting underwriting discounts and estimated offering expenses payable</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not receive any proceeds from the secondary ordinary shares sold by the selling shareholders. We intend to use the net proceeds received to finance a portion of the purchase price for the ProQuest acquisition, which we announced on May 17, 2021. If the ProQuest acquisition is not consummated, we intend to use the net proceeds received for general corporate purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In June 2021, concurrently with the June 2021 Ordinary Share Offering, we completed an underwritten public offering of 14,375,000 of our 5.25% Series A Mandatory Convertible Preferred Shares ("MCPS") which included 1,875,000 of our mandatory convertible preferred shares that the underwriters purchased pursuant to their option to purchase additional shares. The Company received approximately $1,392,671 in net proceeds from the mandatory convertible preferred share offering, after deducting underwriting discounts and estimated offering expenses payable. We intend to use the net proceeds received to finance a portion of the purchase price for the ProQuest acquisition, which we announced on May 17, 2021. If the ProQuest acquisition is not consummated, we intend to use the net proceeds received for general corporate purposes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In September 2021, certain selling shareholders completed an underwritten public offering of 25,000,000 of our ordinary shares at a share price of $25.25, The ordinary shares sold by selling shareholders included 18,000,000 ordinary shares from Onex and 7,000,000 ordinary shares from Baring. The Company did not receive any proceeds from the sale of ordinary shares by the selling shareholders. After giving effect to the offering, Onex and Baring owned approximately 6.7% and 2.6%, respectively, of the Company's ordinary shares.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Risks and Uncertainties</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization characterized COVID-19 as a pandemic. The rapid spread of COVID-19 and the continuously evolving responses to combat it have had an increasingly negative impact on the global economy. In view of the rapidly changing business environment, market volatility and heightened degree of uncertainty resulting from COVID-19, we are currently unable to fully determine its future impact on our business. However, we continue to assess the potential effect on our financial position, results of operations, and cash flows. If the global pandemic continues to evolve into a prolonged crisis, the effects could have an adverse impact on the Company's results of operations, financial condition and cash flows.</span></div>
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	27600000	shares
CY2020Q1	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	20.25
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
CY2020Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	22.50
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	304030000	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
CY2020Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	50400000	shares
CY2020Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	304030000	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	44230768	shares
CY2021Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	26.00
CY2021Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	728080000	USD
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	25000000	shares
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	5491000	USD
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	25.25
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	442117000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	2861000	USD
CY2020Q1	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	18431000	USD
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	619397000	USD
CY2020Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	746478000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8642000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	610755000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16511000	USD
	clvt	Accounts Receivable Allowance For Credit Loss Additional Provisions AccountsReceivableAllowanceForCreditLossAdditionalProvisions	6532000	USD
CY2020	clvt	Accounts Receivable Allowance For Credit Loss Additional Provisions AccountsReceivableAllowanceForCreditLossAdditionalProvisions	4339000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6405000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
	clvt	Accounts Receivable Allowancefor Credit Loss Accounting Change AccountsReceivableAllowanceforCreditLossAccountingChange	0	USD
CY2020	clvt	Accounts Receivable Allowancefor Credit Loss Accounting Change AccountsReceivableAllowanceforCreditLossAccountingChange	10097000	USD
	clvt	Accounts Receivable Allowance For Credit Loss Increase Decrease From Exchange Differences AccountsReceivableAllowanceForCreditLossIncreaseDecreaseFromExchangeDifferences	-230000	USD
CY2020	clvt	Accounts Receivable Allowance For Credit Loss Increase Decrease From Exchange Differences AccountsReceivableAllowanceForCreditLossIncreaseDecreaseFromExchangeDifferences	3000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8642000	USD
	clvt	Noncash Impairment Leases NoncashImpairmentLeases	4880000	USD
CY2020Q3	clvt	Noncash Impairment Leases NoncashImpairmentLeases	110000	USD
	clvt	Noncash Impairment Leases NoncashImpairmentLeases	60232000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8745000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	6405000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	22205000	USD
CY2021Q3	us-gaap	Sublease Income SubleaseIncome	1518000	USD
CY2020Q3	us-gaap	Sublease Income SubleaseIncome	397000	USD
	us-gaap	Sublease Income SubleaseIncome	2288000	USD
	us-gaap	Sublease Income SubleaseIncome	1106000	USD
CY2021Q3	clvt	Noncash Impairment Leases NoncashImpairmentLeases	757000	USD
	clvt	Decrease In Operating Lease Right Of Use Asset DecreaseInOperatingLeaseRightOfUseAsset	60232000	USD
CY2021Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-166000	USD
CY2020Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-745000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-3270000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-882000	USD
CY2020Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-745000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	168049000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	71691000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	73068000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	43743000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36801000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	27948000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	36267000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	2657000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	2918000	USD
	us-gaap	Depreciation Depreciation	9243000	USD
	us-gaap	Depreciation Depreciation	8151000	USD
CY2021Q3	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	257000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-3270000	USD
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-882000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8113820000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1312678000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	6801142000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8153014000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	943909000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	7209105000	USD
CY2021Q3	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8276759000	USD
CY2021Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1312678000	USD
CY2021Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6964081000	USD
CY2020Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8314259000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	943909000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	7370350000	USD
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	128026000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	65696000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	383270000	USD
CY2020Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	978000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	1328045000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	4700138000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-233582000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	6252636000	USD
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	31926000	USD
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	85861000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	6198701000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1737000	USD
CY2019Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.02183
CY2020Q3	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.01695
CY2021Q3	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	-166000	USD
	clvt	Decrease In Operating Lease Right Of Use Asset DecreaseInOperatingLeaseRightOfUseAsset	60232000	USD
CY2021Q3	clvt	Employee Phantom Share Plan Liability Current EmployeePhantomSharePlanLiabilityCurrent	147744000	USD
CY2020Q4	clvt	Employee Phantom Share Plan Liability Current EmployeePhantomSharePlanLiabilityCurrent	193162000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	130594000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	81177000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	98481000	USD
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	50403000	USD
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	67628000	USD
CY2021Q3	us-gaap	Litigation Reserve Current LitigationReserveCurrent	79346000	USD
CY2021Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	69000000	USD
CY2021Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	37052000	USD
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	45119000	USD
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	196999000	USD
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	181372000	USD
CY2021Q3	clvt	Accrued Expenses And Other Current Liabilities Current AccruedExpensesAndOtherCurrentLiabilitiesCurrent	592721000	USD
CY2020Q4	clvt	Accrued Expenses And Other Current Liabilities Current AccruedExpensesAndOtherCurrentLiabilitiesCurrent	716356000	USD
CY2021Q3	clvt	Accrued Legal Fees Current AccruedLegalFeesCurrent	10346000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	368000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	226000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	82000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	79000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	52000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	40000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	4000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	19000	USD
CY2021Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	394000	USD
CY2020Q3	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	246000	USD
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	1104000	USD
	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	661000	USD
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	246000	USD
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	235000	USD
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	156000	USD
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	118000	USD
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	12000	USD
	us-gaap	Defined Benefit Plan Amortization Of Gains Losses DefinedBenefitPlanAmortizationOfGainsLosses	57000	USD
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1600000	USD
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	1182000	USD
	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	721000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	5368526000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3547400000	USD
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	50528000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	51309000	USD
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	8793000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9591000	USD
CY2021Q3	us-gaap	Debt Current DebtCurrent	1865627000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	28600000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3443578000	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3457900000	USD
CY2021Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2021Q3	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	442189000	USD
CY2020Q3	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	286467000	USD
CY2021Q3	clvt	Contractwith Customer Liability Adjustments ContractwithCustomerLiabilityAdjustments	72000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	442117000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284360000	USD
	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	1320657000	USD
	clvt	Revenue From Contract With Customer Excluding Assessed Tax Including Deferred Revenues Adjustment RevenueFromContractWithCustomerExcludingAssessedTaxIncludingDeferredRevenuesAdjustment	805873000	USD
	clvt	Contractwith Customer Liability Adjustments ContractwithCustomerLiabilityAdjustments	4465000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1316192000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	798452000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	737733000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	707318000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	41399000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	610755000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	579935000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	44934000	USD
	clvt	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	126978000	USD
	clvt	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	127383000	USD
	clvt	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	-3535000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	333858000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407325000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	19723000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	238638000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	326098000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	24080000	USD
	clvt	Increase Decrease In Contract With Customer Accounts Receivable IncreaseDecreaseInContractWithCustomerAccountsReceivable	95220000	USD
	clvt	Increase Decrease In Contract With Customer Current Liability IncreaseDecreaseInContractWithCustomerCurrentLiability	81227000	USD
	clvt	Increase Decrease In Contract With Customer Non Current Liability IncreaseDecreaseInContractWithCustomerNonCurrentLiability	-4357000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	485682000	USD
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	339589000	USD
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	78124000	USD
	clvt	Revenue Remaining Performance Obligation Expected Timing Percentage RevenueRemainingPerformanceObligationExpectedTimingPercentage	0.528
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2021Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.472
CY2021Q3	clvt	Revenue Remaining Performance Obligation Percentage Expectedto Be Recognizedin12months RevenueRemainingPerformanceObligationPercentageExpectedtoBeRecognizedin12months	0.236
CY2021Q3	clvt	Revenue Remaining Performance Obligation Percentage Expected To Be Recognized In3 To5 Years RevenueRemainingPerformanceObligationPercentageExpectedToBeRecognizedIn3To5Years	0.175
CY2021Q3	clvt	Revenue Remaining Performance Obligation Percentage Expected To Be Recognized In6 To10 Years RevenueRemainingPerformanceObligationPercentageExpectedToBeRecognizedIn6To10Years	0.062
	clvt	Common Stock Shares Subscription CommonStockSharesSubscription	0	shares
	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	1
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	639750620	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6796000	USD
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
	us-gaap	Common Stock Voting Rights CommonStockVotingRights	one
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	52800000	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	1	shares
CY2020Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	24132666	shares
CY2021Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100.00
CY2021Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100.00
CY2021Q3	us-gaap	Dividends Cash DividendsCash	1000	USD
CY2021Q3	us-gaap	Common Stock Dividends Shares CommonStockDividendsShares	664730	shares
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	16141000	USD
CY2021Q3	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000	USD
CY2021Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	184785000	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	60000000	shares
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11997000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38518000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31121000	USD
CY2021Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	1027000	USD
CY2020Q3	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6862000	USD
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	0	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5114652	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2525000	USD
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	76000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	12021000	USD
	clvt	Stock Issued During Period Shares Private Warrants Exercised StockIssuedDuringPeriodSharesPrivateWarrantsExercised	212174	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	2996000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	565896	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	128642	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	24.43
CY2019Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	52800000	shares
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.50
CY2021Q1	clvt	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	212174	shares
CY2021Q1	clvt	Class Of Warrant Or Right Shares Withheld For Exercise Price ClassOfWarrantOrRightSharesWithheldForExercisePrice	80610	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	131564	shares
	clvt	Stock Issued During Period Shares Private Warrants Exercised StockIssuedDuringPeriodSharesPrivateWarrantsExercised	0	shares
CY2019Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	5309713	shares
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3579000	USD
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	26891000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-177661000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18016000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-64836000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13693000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-323207000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	31871520	shares
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	881000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	881000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-181986000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-181986000	USD
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	640834827	shares
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	387845438	shares
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2021Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	5098686	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	645933513	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	387845438	shares
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-105283000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105283000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-336900000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-336900000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	622460931	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	369019802	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	622460931	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	369019802	shares
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2021Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	427000	USD
CY2020Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3550000	USD
CY2021Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	4838000	USD
CY2020Q3	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-3412000	USD
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-4411000	USD
CY2020Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-138000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-15387000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	10373000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	4354000	USD
	us-gaap	Other Nonrecurring Income Expense OtherNonrecurringIncomeExpense	-4302000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-19741000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	14675000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	442117000	USD
CY2021Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	130683000	USD
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	68614000	USD
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segments
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284360000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1316192000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	798452000	USD
CY2021Q3	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	189996000	USD
CY2020Q3	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	108207000	USD
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3579000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	65194000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	20244000	USD
CY2021Q3	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	72000	USD
CY2020Q3	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	2107000	USD
CY2021Q3	clvt	Transaction Related Costs TransactionRelatedCosts	11851000	USD
CY2020Q3	clvt	Transaction Related Costs TransactionRelatedCosts	34938000	USD
CY2021Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11997000	USD
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6796000	USD
CY2021Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	15621000	USD
CY2020Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	3192000	USD
CY2021Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-83013000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	144753000	USD
CY2021Q3	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	10700000	USD
CY2020Q3	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	5224000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	23312000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2021Q3	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
CY2021Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	881000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-181986000	USD
	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	543815000	USD
	clvt	Adjusted Earnings Before Income Taxes Deprecation Amortization Interest Income And Expense AdjustedEarningsBeforeIncomeTaxesDeprecationAmortizationInterestIncomeAndExpense	286548000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18016000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13693000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	392513000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176200000	USD
	us-gaap	Interest Expense InterestExpense	141156000	USD
	us-gaap	Interest Expense InterestExpense	72306000	USD
	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	4465000	USD
	clvt	Deferred Revenues Adjustment DeferredRevenuesAdjustment	7421000	USD
	clvt	Transaction Related Costs TransactionRelatedCosts	-1599000	USD
	clvt	Transaction Related Costs TransactionRelatedCosts	70154000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38518000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31121000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	121988000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	26792000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-113207000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	224175000	USD
	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	24817000	USD
	clvt	Other Reconciling Items Ebita To Net Income Loss Attributable To Parent OtherReconcilingItemsEBITAToNetIncomeLossAttributableToParent	1586000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-82852000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	22431000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-105283000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-336900000	USD
CY2021Q3	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	69000000	USD
CY2021Q3	us-gaap	Loss Contingency Receivable LossContingencyReceivable	2290000	USD
	us-gaap	Loss Contingency Receivable Proceeds LossContingencyReceivableProceeds	147000	USD
CY2021Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100.00
CY2019Q4	us-gaap	Restructuring Reserve RestructuringReserve	9506000	USD
CY2020Q1	us-gaap	Restructuring Charges RestructuringCharges	7754000	USD
CY2020Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	6647000	USD
CY2020Q1	us-gaap	Restructuring Reserve RestructuringReserve	10613000	USD
CY2020Q2	us-gaap	Restructuring Charges RestructuringCharges	15846000	USD
CY2020Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	5748000	USD
CY2020Q2	clvt	Restructuring Reserve Asset Impairment Charge RestructuringReserveAssetImpairmentCharge	-4908000	USD
CY2020Q2	us-gaap	Restructuring Reserve RestructuringReserve	15803000	USD
CY2020Q3	us-gaap	Restructuring Charges RestructuringCharges	3192000	USD
CY2020Q3	us-gaap	Payments For Restructuring PaymentsForRestructuring	6544000	USD
CY2020Q3	clvt	Restructuring Reserve Asset Impairment Charge RestructuringReserveAssetImpairmentCharge	0	USD
CY2020Q3	us-gaap	Restructuring Reserve RestructuringReserve	12451000	USD
CY2020Q4	us-gaap	Restructuring Reserve RestructuringReserve	21644000	USD
CY2021Q1	us-gaap	Restructuring Charges RestructuringCharges	64667000	USD
CY2021Q1	us-gaap	Payments For Restructuring PaymentsForRestructuring	17037000	USD
CY2021Q1	clvt	Restructuring Reserve Asset Impairment Charge RestructuringReserveAssetImpairmentCharge	-42215000	USD
CY2021Q1	us-gaap	Restructuring Reserve RestructuringReserve	27059000	USD
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	41700000	USD
CY2021Q2	us-gaap	Payments For Restructuring PaymentsForRestructuring	12882000	USD
CY2021Q2	clvt	Restructuring Reserve Asset Impairment Charge RestructuringReserveAssetImpairmentCharge	-20584000	USD
CY2021Q2	us-gaap	Restructuring Reserve RestructuringReserve	35293000	USD
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	15621000	USD
CY2021Q3	us-gaap	Payments For Restructuring PaymentsForRestructuring	15722000	USD
CY2021Q3	clvt	Restructuring Reserve Asset Impairment Charge RestructuringReserveAssetImpairmentCharge	-812000	USD
CY2021Q3	us-gaap	Restructuring Reserve RestructuringReserve	34380000	USD
CY2021Q3	us-gaap	Restructuring Charges RestructuringCharges	15621000	USD
CY2020Q3	us-gaap	Restructuring Charges RestructuringCharges	3192000	USD
	us-gaap	Restructuring Charges RestructuringCharges	121988000	USD
	us-gaap	Restructuring Charges RestructuringCharges	26792000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284360000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	93554000	USD
CY2020Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	131526000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	2918000	USD
CY2020Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	65696000	USD
CY2020Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	3192000	USD
CY2020Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-138000	USD
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	297024000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-12664000	USD
CY2020Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	144753000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-157417000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	20244000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	224175000	USD
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-177661000	USD
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4325000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.47
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.47
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	387845438	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	387845438	shares
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	798452000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	268614000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	368247000	USD
	us-gaap	Depreciation Depreciation	8151000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	168049000	USD
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	26792000	USD
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	14675000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	825178000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-26726000	USD
	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-250901000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	369019802	shares
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
	us-gaap	Interest Expense InterestExpense	72306000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-323207000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13693000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	369019802	shares
CY2020Q3	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1092000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	15000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9359000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10436000	USD
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-171550000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-2052000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	539714000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16384000	USD
	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	57000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1795000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-314000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-337214000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1248599000	USD
CY2020Q1	clvt	Stock Issued During Period Value Public Warrants Exercised StockIssuedDuringPeriodValuePublicWarrantsExercised	277526000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1182000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	10302000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-129633000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-8470000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1925681000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	15118000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	304030000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4322000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-25281000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2280000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	2191354000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	125000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	3136000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5520000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-181986000	USD
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10436000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	2022313000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-336900000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	176200000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1830000	USD
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	1052000	USD
	clvt	Noncash Impairment Leases NoncashImpairmentLeases	4880000	USD
	clvt	Gain Loss On Foreign Currency Forward Contracts GainLossOnForeignCurrencyForwardContracts	2903000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-7420000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	26344000	USD
	clvt	Mark To Market Loss On Contingent Shares MarkToMarketLossOnContingentShares	30839000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	224175000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-3140000	USD
	clvt	Other Non Cash Income Expense Excluding Gain On Sale Of Line Of Business OtherNonCashIncomeExpenseExcludingGainOnSaleOfLineOfBusiness	3902000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-129398000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	13335000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-62818000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-8394000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-65062000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-65062000	USD
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-93926000	USD
	clvt	Increase Decrease Operating Lease Right Of Use Assets IncreaseDecreaseOperatingLeaseRightOfUseAssets	-5826000	USD
	clvt	Increase Decrease Lease Liabilities IncreaseDecreaseLeaseLiabilities	6611000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2077000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	128022000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	78597000	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	885323000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	5982000	USD
	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	3751000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-966151000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	9450000	USD
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	65000000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5267000	USD
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	4115000	USD
	clvt	Proceeds From Debt Restructure ProceedsFromDebtRestructure	360000000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	843752000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	277526000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1307000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1307000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	28674000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1370079000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-6447000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	525503000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76130000	USD
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	9000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	76139000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	601642000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	601075000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	567000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	601642000	USD
	us-gaap	Interest Paid Net InterestPaidNet	61796000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	20147000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	922000	USD
CY2021Q2	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100.00

Files In Submission

Name	View Source	Status
0001764046-21-000165-index-headers.html	Edgar Link	pending
0001764046-21-000165-index.html	Edgar Link	pending
0001764046-21-000165.txt	Edgar Link	pending
0001764046-21-000165-xbrl.zip	Edgar Link	pending
clvt-20210930.htm	Edgar Link	pending
clvt-20210930.xsd	Edgar Link	pending
clvt-20210930_cal.xml	Edgar Link	unprocessable
clvt-20210930_def.xml	Edgar Link	unprocessable
clvt-20210930_htm.xml	Edgar Link	completed
clvt-20210930_lab.xml	Edgar Link	unprocessable
clvt-20210930_pre.xml	Edgar Link	unprocessable
exhibit31-q32021.htm	Edgar Link	pending
exhibit32-q32021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLVT
CLARIVATE PLC Stock $clvt

2021 Q3 Form 10-Q Financial Statement

#000176404621000165 Filed on October 28, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT CLARIVATE PLC Stock $clvt

2021 Q3 Form 10-Q Financial Statement

#000176404621000165 Filed on October 28, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLVT
CLARIVATE PLC Stock $clvt